Orchid Pharma board okays 500-cr QIP fund raising
Shares of Orchid Pharma closed 2.64 per cent02-12-2022
02-12-2022
Orchid Pharma Ltd - 524372 - Orchid Pharma Limited Has Informed The Exchange About EGM Date, Remote E- Voting And Book Closure With Reference To The Upcoming EGM To Be Held On December 29, 2022.
Orchid Pharma Limited has informed the Exchange about EGM Date, Remote E- Voting and Book Closure with reference to the upcoming EGM to be held on December 29, 2022.02-12-2022
Orchid Pharma board approves QIP programme to raise Rs 500 crore
Drug firm Orchid Pharma on Thursday said its board has approved to raise Rs 500 crore from institutional investors. The company's board has approved a Qualified Institutional Placement (QIP) programme to raise Rs 500 crore, it said in a regulatory filing. With this QIP, the Dhanuka group, which took over the company in 2018, is also meeting its mandatory obligation to dilute 15 per cent stake in it by March 2023. Post a successful turnaround of the Insolvency Bankruptcy Code case, the company has been on a growth spree, it said. On the back of a robust product launch pipeline and an agile management team, the company said it is poised to become an even stronger player in the Cephalosporin antibiotics space.02-12-2022
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Corrigendum to the Press Release Dated December 01, 202201-12-2022
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release01-12-2022
Orchid Pharma Ltd - 524372 - Board Meeting Outcome - Announcement Under Reg. 30, SEBI LODR 2015.
Board Meeting Outcome - Announcement under Reg. 30, SEBI LODR 2015.01-12-2022
Orchid Pharma Ltd - 524372 - Disclosure Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 201528-11-2022
Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Board Meeting Intimation Under Regulation 29 Of SEBI Listing Obligations And Disclosure Requirements) Regulations, 2015
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/12/2022 ,inter alia, to consider and approve Board Meeting Intimation under Regulation 29 of SEBI Listing Obligations and Disclosure Requirements) Regulations, 201528-11-2022
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Orchid Pharma Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call23-11-2022
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio Recording of the Investor Call held on November 18, 2022.18-11-2022